Goldman Sachs raised the firm’s price target on RenaissanceRe (RNR) to $267 from $250 and keeps a Sell rating on the shares. In a sector note on Americas Insurance, the firm said it expects “strong and fairly resilient” insurer profitability for the next few years, but added that it believes we are “solidly in the softening phase” of the P&C insurance cycle, which leads to “increased capital supply and competition, which should drive a deceleration in growth/pricing/margins, that we think are broadly underappreciated within Street estimates.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNR:
- RenaissanceRe price target raised to $283 from $250 at Evercore ISI
- RenaissanceRe price target raised to $329 from $303 at JPMorgan
- RenaissanceRe price target raised to $314 from $270 at Keefe Bruyette
- RenaissanceRe Extends Secured Letter of Credit Facility
- RenaissanceRe price target raised to $300 from $290 at Morgan Stanley
